2025-06-06-Bernstein-印度人寿保险_利润率扩张_增长反弹和监管重置推动上行——保持乐观_24页_1mb

6 June 2025
India Asset Management & Insurance

Overall Analysis & Recommendation

• Positive Outlook: Remain positive on Indian life insurance stocks, valuations supportive despite strong run-up. Drivers: Improved growth/margin expansion outlook and reversal in regulatory pessimism.
• Stock Ratings:
  • Outperform (O): Max Financial (MAXF), SBI Life Insurance (SBILIFE), HDFC Life Insurance (HDFCLIFE)
  • Market-Perform (M): ICICI Prudential Life Insurance (IPRU), Life Insurance Corp (LICI)

Key Points

1. The Catch-Up Trade Remains Valid

• Strong returns over the last year/YTD despite earlier pessimism.
• Bank-channel sales sentiment improved, supported by valuation and product-mix shifts (higher margin riders, tenure max.).
• Expect further investor sentiment improvement post-IRDAI chairman finalization and key amendments.
• Regulatory scrutiny on bank-channel sales could pressure credit-life insurance but may spare other products.

2. Better Bottom-Line Growth Expectations

• ULIP sales expected soft in FY26 due to base effect, but margin pick-up will boost NBP growth.
• Transition to par/non-par savings, term plans, annuities expected, favoring product mix shift.
• Higher product-level margins anticipated via rider attachment and tenure maximization.
• Valuation multiples improved due to improved visibility on growth + regulatory sentiment.

3. Expectations of a Regulatory Reset

• Regulatory uncertainty (often pro-consumer) was a key headwind previously.
• Clarifications suggest ongoing scrutiny, but bank-channel sales are not being capped (except credit-life).
• Long-term pressure on microfinance-linked credit-life remains. Bank sales of other products less affected.
• Pro-growth stance of RBI and SEBI authorities provides comfort. Insurers also boosting agency force as channel diversification strategy.

4. Model Update

• Estimated multiples increased reflecting better visibility on future growth (esp. FY26/27).
• Regulatory normalcy expected soon, countering past severe multiple compression.

5. Investment Recommendations Summary Table:

Detailed Company Analysis Summary

6.1 Max Financial Services Ltd (MAXF - Outperform)

• Rating Update: Increase TP to INR 1,930 (hike from INR 1,505).
• Growth/Profit: Robust top-line growth through FY26-28 driven by brand awareness, Tier II/III focus, rebranding ($389 bn INR). ~ INR 8.4% YOY growth expected initially via APE/CAGR gains.
• Margins: 100 bps margin increase guided; potential upside from rider/tenure measures; moderated for FY26 given prior guidance, but potential for further improvement.
• Valuation: 2.8x FY26 EV, 18x FY27 NBP.

6.2 SBI Life Insurance Co Ltd (SBILIFE - Outperform)

• Rating: Hike TP to INR 2,190 from INR 2,040.
• Growth: Relies on agency channel expansion to offset banca slowdown. growth guides lower than peers.
• Margins: Near-term pressure balancing agent margin drawdown vs. mix shift + lower FIRB limit SIPV impact. HTM strategy key, refocus on protection.
• Valuation: 2.7x FY26 EV, 18x FY27 NBP.

6.3 HDFC Life Insurance Co Ltd (HDFCLIFE - Outperform)

• Rating: Hike TP to INR 920 from INR 840.
• Growth: Agency channel focus, Tier II/Tier III market deepening, counter-share stable.
• Margins: Positioned for margin expansion via rider/tenure optimization and product mix shift.
• Valuation: 3.1x FY26 EV, 24x FY27 NBP (Target says Low staggered mul, but see product mix shifting towards higher margin products). (Note: Valuation multiple/TP hike).

6.4 ICICI Prudential Life Insurance Co Ltd (IPRU - Market-Perform)

• Rating: Hold TP at INR 720 (flat from INR 760).
• Group business dilutes margin profile despite high growth.
• Adverse actuarial adjustments (group-term mortality) and unfavorable vs budget estimates.
• Volatility remains, especially concerning broker channel mix and pure-play group fund ALM.

6.5 Life Insurance Corp of India (LICI - Market-Perform)

• Rating: Hold TP at INR 1,070 (down from INR 1,190).
• Liquidity risk from government holding.
• Regulatory precursors for diversification to non-life insurance.
• Watchful reliance on strong FY26 guidance fulfillment and margin expansion.

Disclosures: Standard disclaimer attached. Analyst maintain positions and received compensation from listed companies previously/discussed.